Author

Antón Aparicio

Observed names: A Aparicio, Antón Aparicio, L. M., L M Antón Aparicio

OpenAlex ID: A5004172575

Cohort compassionate-use program and early access program with cabazitaxel plus prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel: analysis by age group

2015 · Malik, Z., Di Lorenzo, G., et al. · RWTH Publications (RWTH Aachen)

Cabazitaxel for metastatic castration-resistant prostate cancer: Safety data from the Spanish Early Access Programme

2013 · Antón Aparicio, L. Silva Miguel · European Journal of Cancer

Abstract P6-04-12: Novel selective estrogen receptors degraders regress tumors in pre-clinical models of endocrine-resistant breast cancer

2012 · JH Hager, B Darimont, et al. · Cancer Research

[Protein A: an immunomodulator in cancer patients].

1988 · M L Subirá, A Sánchez Ibarrola, et al. · PubMed

[The terminal disease syndrome: criteria and attitudes].

1988 · A C Gil, P Herranz, et al. · PubMed

Works count: 5

Citation count:

H-index:

I10-index: